Comments on Facebook

Popular Stories in Health/Fitness

CEL-SCI Corporation announced it has added a second clinical site for its Phase I clinical trial evaluating peri-anal wart immunotherapy in HIV/HPV co-infected men and women with its investigational cancer immunotherapy Multikine.

Smartphone apps are the latest tools to emerge from the intersection of health care and Silicon Valley, where tech companies are also working on new ways of bringing patients and doctors together online.

In this week's Ask the Doc column, Dr. Howard Scheiner takes a realistic look at the latest studies around Pre-Exposure Prophylaxis (PrEP) with Truvada, and lets you know what you'll have to do to keep safe this summer.